The federal government has asked a court to impose a $706 million civil penalty against long-term care pharmacy Omnicare and its parent company, CVS Health Corp., in the wake of rulings against the ...

CVS Health Corp. carries some liability for helping its long-term care pharmacy subsidiary, Omnicare, submit fraudulent drug claims for assisted living and other non-skilled nursing residential ...

Forty oximeters were recently donated to the Omnicare Trust in support of its mission to deliver quality healthcare to Namibia’s remote communities.The donation, valued at N$58 000, was made by FNB ...

Access to quality healthcare in remote communities is set for a significant boost following a donation of 40 oximeters to the ...

The petition, expected to become public Monday, puts CVS on notice that workers in its Omnicare pharmacy in Las Vegas intend to hold an election to determine whether the newly formed guild should ...

SAN FRANCISCO (CBS.MW) -- Omnicare launched a tender offer for smaller rival NeighborCare late Thursday that is, in financial terms, virtually identical to its earlier, rejected proposals.

According to the release, at the heart of the allegations were "emergency kits," provided by Omnicare to the facilities, that often included opioids and controlled substances that are commonly ...

A complete guide to lease accounting for healthcare organizations Making a successful transition to the latest lease accounting requirements such as ASC 842, IFRS 16 or GASB 87 can be a complicated ...

The lawsuit alleges that from 2010 to 2018, instead of getting new prescriptions from patients' doctors, Omnicare's pharmacies just "rolled over" the prescriptions. (Photo: Shutterstock ...

The federal government accused pharmacy giant CVS Health and its Omnicare business of fraudulently billing federal health programs for hundreds of thousands of drugs dispensed without prescriptions.

CVS Health isn’t ready to sell its Omnicare long-term care pharmacy business because executives see potential in an aging U.S. population with complex prescription needs. Wall Street analysts ...